Carnegie acted as manager in the fully underwritten NOK 180 million rights issue. Observe Medical develops and markets and sells innovative hospital products that contribute to increased patient safety and a more efficient care system. The Company’s ambition is to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in the areas of Urine measurement, Anesthesiology/ICUs and wound care, in combination with targeted M&A.
February 2022.
Healthcare
Fully underwritten rights issue rights issue in Observe Medical ASA (NO) — NOK 180 million
February 2022